Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

326
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal clinically important difference (MCID), patient-acceptable state (PASS), minimally detectable change (MDC), and substantial clinical benefit (SCB) in patients who have undergone arthroscopic surgery for femoroacetabular impingement: a systematic review.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology·2026
Same author

[Lumbar disc herniation].

Orthopadie (Heidelberg, Germany)·2026
Same author

Development and evaluation of cross-linked fracturing fluid stability and scale inhibition synergy in high-temperature, high-salinity environments.

Scientific reports·2026
Same author

Complex Soft Tissue Injuries Following Elevator Door Entrapment: A Case Report Including Surgical Management Principles.

Cureus·2026
Same author

Utility of Direct Fick Cardiac Output in Patients with Left Ventricular Assist Devices.

Journal of cardiac failure·2026
Same author

High-temperature and high-salinity performance of chelating agents for oilfield scale inhibition with dynamic scale loop.

Scientific reports·2026

Related Experiment Video

Updated: Jun 17, 2025

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.0K

Management of Post-Myocardial Infarction Right Ventricular Failure.

Justin Haloot1, Mohamed Mahmoud1, Anand Prasad1

  • 1Division of Cardiology, Department of Medicine, University of Texas Health San Antonio, San Antonio, Texas.

Journal of the Society for Cardiovascular Angiography & Interventions
|August 12, 2024
PubMed
Summary

Right ventricular failure (RVF) after acute myocardial infarction (MI) is serious. This review covers RVF pathophysiology, management, and support, highlighting limited data for MI-induced RVF.

Keywords:
STEMIcardiogenic shockmechanical circulatory supportmyocardial infarctionright ventricular failure

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Related Experiment Videos

Last Updated: Jun 17, 2025

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.0K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Right ventricular failure (RVF) following acute myocardial infarction (MI) presents significant morbidity and mortality.
  • Current management strategies for post-MI RVF are largely based on expert consensus and extrapolated data from other causes of RVF.
  • There is a notable scarcity of specific clinical data for managing RVF directly linked to acute MI.

Purpose of the Study:

  • To comprehensively review the existing literature on right ventricular failure secondary to acute myocardial infarction.
  • To elucidate the pathophysiology, diagnostic considerations, and therapeutic interventions for MI-induced RVF.
  • To discuss hemodynamic monitoring, medical management, and mechanical circulatory support options.

Main Methods:

  • Literature review of current scientific articles and expert consensus guidelines.
  • Synthesis of information regarding pathophysiology, clinical presentation, and management strategies.
  • Analysis of data on hemodynamic monitoring and mechanical support interventions.

Main Results:

  • RVF in acute MI is associated with poor outcomes, necessitating prompt recognition and intervention.
  • Management relies on general principles due to limited specific evidence for MI-induced RVF.
  • A multi-faceted approach involving hemodynamic monitoring, medical therapy, and potentially mechanical support is crucial.

Conclusions:

  • Effective management of MI-induced RVF requires a thorough understanding of its pathophysiology and current therapeutic options.
  • Early recognition, prompt revascularization, and tailored hemodynamic management are key.
  • Further research is needed to establish evidence-based guidelines for this specific patient population.